While our prior work established that HIV-1 increased APP processing to evade its antiviral effects, how infection impacts amyloidogenic versus non-amyloidogenic CTFs and the underlying mechanism by which APP inhibits infection remain unknown. This evidence concerns the gene APP and infection.